Clinical Trial Update: Acute Effects of Cannabigerol [Phase 1]

View source ↗

Summary

Phase 1 clinical trial investigating the acute effects of cannabigerol (CBG) on anxiety, stress, and cognition has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders

Drugs mentioned

• Cannabigerol (CBG) (cannabigerol)

Snippet

Sponsor: Washington State University | Conditions: Focus: To Examine Acute Effects of CBG on Anxiety, Stress, and Cognition | Phase 1 | Status: COMPLETED